secwatch.observer — SEC 8-K summary
======================================

Issuer:     Amphastar Pharmaceuticals, Inc. (AMPH)
CIK:        0001297184
Form:       8-K
Filed at:   2025-07-21T23:59:59+00:00
Accession:  0001297184-25-000040
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Amphastar appoints David Gaugh as Class I director; board size increased to 11
------------------------------------------------------------------------------

- Board increased authorized directors from 10 to 11 and appointed David Gaugh effective July 18, 2025.
- Gaugh will serve until the 2026 annual meeting; no committee assignments at this time.
- Initial compensation: $260,000 aggregate grant date fair value, 50% RSUs and 50% stock options, vesting on first anniversary.
- Board determined Gaugh is independent under Nasdaq listing standards; no reportable transactions or arrangements.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1297184/000129718425000040/0001297184-25-000040-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1297184/000129718425000040/amph-20250718x8k.htm
  HTML page:      https://secwatch.observer/filing/0001297184-25-000040

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer